JSD decreased expression levels of TGF-β and MMP-9 secreted by carcinoma-associated fibroblasts and lowered mRNA levels of α-SMA and TGF-β, thereby inhibiting migration capability of colon cancer CT-26 cells [12]. The gene discussed is TGFB1; the disease is malignant colon neoplasm.